Based on what I read, this "study" is just a review and consolidation of other actual studies. They didn't do any science here. However, in the "Results" section of the abstract it does state "Fifteen original studies were selected. Preclinical trials were able to reduce amyloid-b plaques and tau phosphorylation, improving cognitive performance in AD animals."
Also, in the studies they consolidated there are several that mention in their results that it breaks up the plaques. For example: "Jordão et al., 201010 Mouse FUS associated with administration of anti-b-amyloid antibody (BAM 10) in transgenic mice (TgCRND8) promoted a significant reduction of b-amyloid peptide plaques."
sharkbait 0 points 11 months ago
Based on what I read, this "study" is just a review and consolidation of other actual studies. They didn't do any science here. However, in the "Results" section of the abstract it does state "Fifteen original studies were selected. Preclinical trials were able to reduce amyloid-b plaques and tau phosphorylation, improving cognitive performance in AD animals."
Also, in the studies they consolidated there are several that mention in their results that it breaks up the plaques. For example: "Jordão et al., 201010 Mouse FUS associated with administration of anti-b-amyloid antibody (BAM 10) in transgenic mice (TgCRND8) promoted a significant reduction of b-amyloid peptide plaques."